Építés alatt – nem éles oldal
Belépés

What researchers published on Mielóma multiplex

24 549 papers, newest first.

Showing 174 of 24 549

  • Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial.Blood
  • ÁttekintésMacrophage Immunometabolic Reprogramming in Multiple Myeloma: Linking Spatial Niches to Therapy Resistance.Immunological investigations
  • A real-time text-based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study.British journal of haematology
  • Prognostic value of neutrophil-to-lymphocyte ratio among patients suffering from multiple myeloma: A systematic review and meta-analysis.Therapeutic advances in hematology
  • Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody.Blood
  • ÁttekintésNovel insights into the bone microenvironment in myeloma bone disease.Journal of bone oncology
  • EsetismertetésDetection of Urinary Round Cells in a Dog With IgA Paraproteinemia: A Case of Myeloma-Related Disorder.Veterinary clinical pathology
  • ÁttekintésEarly-line immunotherapy in multiple myeloma: reshaping the treatment paradigm.Frontiers in immunology
  • EsetismertetésIntegrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R-Associated Chromatin Remodeling: A Case Report.Cancer reports (Hoboken, N.J.)
  • Ocular comorbidities are common in multiple myeloma: results of a large cross-sectional survey.The oncologist
  • EsetismertetésMultiple myeloma presenting with cavernous sinus syndrome: A case report and literature review.SAGE open medical case reports
  • Phase 3 trial data point to more options for patients with relapsed or refractory multiple myeloma: Teclistamab- and mezigdomide-based regimens could expand treatment options, set new standards of care, and improve survival.Cancer
  • EsetismertetésDiffuse abdominal calcifications in a patient with multiple myeloma and AL amyloidosis.The American journal of medicine
  • Treatment Patterns, Treatment Response, and Survival Outcomes in Patients with Multiple Myeloma: A Single-Center Real-World Study.Journal of clinical medicine
  • FedMann: A Manually Coordinated Federated Learning Framework Applied to Multiple Myeloma-A Feasibility Study.Journal of clinical medicine
  • Lower Dexamethasone Dose in Multiple Myeloma: A Multicenter Retrospective Analysis.Cancers
  • ÁttekintésMultiple Myeloma Measurable Residual Disease: Spotting Three Different Detection Methods.International journal of molecular sciences
  • ÁttekintésApproach to Patients with Multiple Myeloma after BCMA targeted Therapy.Current hematologic malignancy reports
  • Infectious complications after anti-BCMA CAR-T cell therapy in patients with multiple myeloma: a systematic literature review.Antimicrobial stewardship & healthcare epidemiology : ASHE
  • Megfigyeléses vizsgálatNutritional Risk, Weight Loss, and Inflammatory Profiles During Autologous Stem Cell Transplantation: Clinical Correlates in Patients with Lymphoma and Multiple Myeloma.Nutrients
  • ÁttekintésAchievement and Persistence of MRD Negativity with Anti-CD38-Based Regimens in Newly Diagnosed Multiple Myeloma: A Systematic Review and Network Meta-Analysis.Cancers
  • ÁttekintésThree-dimensional models of the multiple myeloma bone microenvironment: from disease mechanisms to translational applications.Frontiers in cell and developmental biology
  • Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma.Blood cancer journal
  • Metabolic targeting of multiple myeloma using the Warburg Trap.Cancer cell international
  • Successful long-term management of severe psoriasis with secukinumab after autologous hematopoietic stem cell transplantation for multiple myeloma: a case report.Anais brasileiros de dermatologia
  • Szisztematikus áttekintésProgressive multifocal leukoencephalopathy, bispecific antibodies, and multiple myeloma: a case report and systematic review of the literature.Frontiers in oncology
  • Enhancing clinical teaching in hematology: a retrospective study on the integration of the PDCA cycle with case-based learning.BMC medical education
  • Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.Haematologica
  • EsetismertetésHemiarthroplasty with a long femoral stem and proximal cement augmentation for a myeloma-related pathological femoral neck fracture: a case report.Frontiers in surgery
  • Understanding multiple myeloma: insights into patients' experiences and preferences for communication, information and support.Hematology (Amsterdam, Netherlands)
  • Pentraxin-3 dynamics and treatment response in newly diagnosed multiple myeloma.International journal of hematology
  • Response to Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".Haematologica
  • Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome.Haematologica
  • ÁttekintésMultiple myeloma bone disease models with integrated bone marrow adipose tissue for advancing personalized medicine.Frontiers in oncology
  • Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice.Cancer letters
  • Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010).Blood cancer journal
  • Flame Cells and Cohesive Plasma-Cell Clusters in IgD-Lambda Multiple Myeloma.Cytopathology : official journal of the British Society for Clinical Cytology
  • Szisztematikus áttekintésPredictors of cardiovascular events in multiple myeloma: a systematic review and exploratory meta-analysis.Frontiers in cardiovascular medicine
  • Development and multicenter validation of a predictive nomogram for infection risk in patients with multiple myeloma.Annals of hematology
  • Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First-Year Biomarker Trajectories Identified by Group-Based Trajectory Modeling.Cancer medicine
  • Cyclophosphamide maintenance in multiple myeloma without transplantation: A real-world study.Leukemia research
  • Disease perception, quality of life and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma following treatment: a cross-sectional survey study.Journal of comparative effectiveness research
  • EsetismertetésUnilateral Angle Closure as the Initial Presentation of Multiple Myeloma Metastasis.Journal of ophthalmic & vision research
  • EsetismertetésMultiple myeloma with extramedullary small bowel plasmacytoma presenting as a pyrexia of unknown origin: a case report.Journal of medical case reports
  • T cell redirection in high-risk smouldering multiple myeloma: can deep responses prevent progression to multiple myeloma?Nature reviews. Clinical oncology
  • ÁttekintésEpitranscriptomic regulation contributes to multiple myeloma biology and offers potential therapeutic targets.Neoplasia (New York, N.Y.)
  • Szisztematikus áttekintésPhysiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Impact of socioeconomic status on treatment and survival in multiple myeloma in Australia.Blood cancer journal
  • Megfigyeléses vizsgálatDivergent Cost Trends for 3 Advanced Cancers, 2013 vs 2022: A Commercial Claims Analysis.The American journal of managed care
  • EsetismertetésMultiorgan [18F]florbetapir PET/CT uptake in multiple myeloma-associated systemic AL amyloidosis: a case report.Medical oncology (Northwood, London, England)
  • Spiritual beliefs and preferences among patients with multiple myeloma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Construction and validation of a differential diagnosis model for multiple myeloma and lymphoma based on XGBoost machine learning: an explaining analysis study of SHAP.BMC medical informatics and decision making
  • GPRC5D-Directed Antibodies in Multiple Myeloma: New Agents and Frontline Strategies From IMS 2026.Clinical lymphoma, myeloma & leukemia
  • Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Genomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma.JCI insight
  • Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?British journal of haematology
  • IL-6-driven metabolic reprogramming of the multiple myeloma microenvironment.Cancer & metabolism
  • Esetismertetés[Multiple myeloma with central nervous system involvement successfully treated with a multimodal therapy including elranatamab].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Esetismertetés[Multiple myeloma presenting with left abducens nerve palsy due to sphenoid sinus plasmacytoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • PreprintGenomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones.bioRxiv : the preprint server for biology
  • Multiple Myeloma in a Resource-Limited Setting: Clinical Presentation, Treatment Patterns, and Outcomes From a 99-Patient Cohort in Senegal.EJHaem
  • FcRH5-Targeted Therapy in Multiple Myeloma: Evolving Clinical Strategies and Resistance From IMS 2026.Clinical lymphoma, myeloma & leukemia
  • Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.Transplantation and cellular therapy
  • Influence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma.Bone marrow transplantation
  • EsetismertetésUndetected Intracellular Immunoglobulin Light Chains in Aberrant Plasma Cells of Multiple Myeloma by Monoclonal Antibody-Based Flow Cytometry: A Question Raised by a Single Case.Journal of immunology research
  • ÁttekintésBridging Innovation in Multiple Myeloma Care: A Review of Novel Therapies.Journal of the advanced practitioner in oncology
  • ÁttekintésEarly Treatment Failure in Real-World Bispecific-Antibody Therapy for Relapsed or Refractory Multiple Myeloma: Pathways, Determinants, and Measurement Gaps.OncoTargets and therapy
  • Prognostic significance of IgG-Kappa positivity detected by serum immunofixation during daratumumab therapy in multiple myeloma.Upsala journal of medical sciences
  • EsetismertetésEpithelioid Angiosarcoma Masquerading as Multiple Myeloma: A Diagnostic Pitfall.Cureus
  • CDK4/6i reverses MEIS2 inhibition of CRL4CRBN and promotes BCMA loss to enhance IMiD/CELMoD therapy in multiple myeloma.Blood neoplasia
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0.Journal for immunotherapy of cancer
  • Orthopnea From Phrenic Nerve Palsy After Ciltacabtagene Autoleucel CAR T-Cell Therapy in a Patient With Multiple Myeloma.Journal of the advanced practitioner in oncology
  • Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma.Clinical hematology international
  • PreprintComputational alternative to cardiac biopsy in multiple myeloma: utilizing the shape of routine laboratory data for the classification of AL cardiac amyloidosis.bioRxiv : the preprint server for biology
  • Succinate promotes multiple myeloma cell proliferation through TCA cycle oxidation.Cell reports
  • ÁttekintésCombination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.The Lancet. Infectious diseases
  • EsetismertetésLenalidomide-associated B-cell acute lymphoblastic leukemia in a multiple myeloma patient: a case report.Journal of medical case reports
  • ÁttekintésPractical Recommendations for Implementing Remote Patient Monitoring for Patients Receiving Bispecific Antibodies for Multiple Myeloma.JMIR cancer
  • AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
  • Statement of Retraction: A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis.Bioengineered
  • Esetismertetés[Personalized Dosing of Lenalidomide Based on Integrated Assessment of Renal Function and Frailty in Multiple Myeloma].Gan to kagaku ryoho. Cancer & chemotherapy
  • Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab-based combination therapy.British journal of haematology
  • The impact of pomalidomide-containing induction on stem cell mobilization and engraftment in multiple myeloma: a single-center experience.Annals of hematology
  • Machine-Learning-Guided Identification of CCT245737 as a Functional Pan-G-Quadruplex Ligand for the Treatment of Multiple Myeloma.The journal of physical chemistry. B
  • Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
  • An Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients.Transplantation and cellular therapy
  • Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma.Blood cancer journal
  • ÁttekintésBispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.Cancer
  • Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma.British journal of haematology
  • EsetismertetésIntrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review.AACE endocrinology and diabetes
  • Bone recovery after treatment study: Evidence of myeloma bone disease repair and partial microenvironment recovery.British journal of haematology
  • Is Targeted Molecular Imaging of Multiple Myeloma the Future?Radiology
  • Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.Nature medicine
  • ÁttekintésGenomics-Guided Risk Stratification in Myeloma Precursor Conditions: Converging Frameworks From Whole-Genome Sequencing.Technology in cancer research & treatment
  • ÁttekintésPredictors of Malnutrition in Patients With Multiple Myeloma: A Review of the Literature.Medical science monitor : international medical journal of experimental and clinical research
  • Whole-body low-dose computed tomography image quality and radiation dose in multiple myeloma: A comparison between 64-slice and 128-slice scanners.Journal of clinical imaging science
  • Oral versus intravenous melphalan for autologous stem cell transplantation conditioning in lymphoma and multiple myeloma: a retrospective cohort study.Frontiers in oncology
  • EsetismertetésSolitary skull lesion as the initial presentation of multiple myeloma: A case report and review of the literature.Surgical neurology international
  • Real-World Experience of Using Next-Generation-Sequencing in Multiple Myeloma Diagnostics in the UK National Health Service.Clinical lymphoma, myeloma & leukemia
  • Bone Marrow T-Cell Transcript Content Predicts Survival in Relapsed and Refractory Multiple Myeloma and Accounts for the Apparent Prognostic Value of T-Cell Exhaustion Signatures.Current medicinal chemistry
  • Vizsgálati eredményPhase 2 Trial of 89Zr-Deferoxamine-Daratumumab for CD38-targeted Immuno-PET/CT Detection of Multiple Myeloma.Radiology
  • ÁttekintésDiscordant marrow MRD and PET-CT in myeloma: A four-state language for joint reporting.British journal of haematology
  • Identification of B-cell maturation antigen (BCMA)-targeting peptides and selective drug delivery to multiple myeloma using peptide-targeted DM1 prodrug-loaded nanoparticles.Nanoscale advances
  • Quantification of lenalidomide and pomalidomide enantiomers in multiple myeloma patients: An exploratory study.Indian journal of pharmacology
  • Bringing Treatment Home: Daratumumab Administration by Danish Community Nurses in Multiple Myeloma-A Mixed-Method Study.Home healthcare now
  • PPIA as a central regulator in a novel cell death pathway activated by iron homeostasis and redox disruption in multiple myeloma.Acta biochimica et biophysica Sinica
  • Erratum to: "Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way".Haematologica
  • Rewiring of oncogenic pathways confers carfilzomib resistance in multiple myeloma and is reversed by Rap1 inhibition.Acta biochimica et biophysica Sinica
  • Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting Analysis.Advances in therapy
  • Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study.Blood cancer journal
  • Targeting the circ_0042819-PLA2G6 axis sensitizes multiple myeloma to proteasome inhibitors through ferroptosis induction.Cell death and differentiation
  • The Steroid Symptom Questionnaire Multiple Myeloma (SSQ-MM): translation and cross-cultural adaptation into Danish and Norwegian and initial psychometric evaluation of the Norwegian version.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
  • Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection.Journal of clinical apheresis
  • MANF promotes cell fitness and attenuates bortezomib sensitivity in multiple myeloma.Translational oncology
  • Fiscal burden of multiple myeloma in Croatia: a whole-of-government analysis.Croatian medical journal
  • Rethinking immunotherapy sequencing in multiple myeloma: a conceptual adaptive immunotherapy sequencing model.Frontiers in immunology
  • A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma.Blood neoplasia
  • Single-cell analysis reveals favorable responses of tumor-associated monocytes to bortezomib-based treatment in multiple myeloma.NPJ precision oncology
  • Problematic control arms in National Cancer Institute myeloma trials.Nature reviews. Clinical oncology
  • Beyond binary: graded frailty assessment and outcomes after CAR-T cell therapy in relapsed/refractory multiple myeloma.Blood cancer journal
  • Multiphoton Imaging of the Tibial Bone Marrow for In Vivo Spatial-Temporal Analysis of Myeloma Microenvironment and Treatment.Methods in molecular biology (Clifton, N.J.)
  • EsetismertetésMultiple Myeloma Presenting as a Pancoast-Like Tumor: A Diagnostic Challenge.Cureus
  • ÁttekintésImmunotherapy in multiple myeloma: Molecular mechanisms, current clinical strategies, resistance, and future perspectives.Seminars in oncology
  • Glomerular diseases associated with multiple myeloma: renal pathology and survival outcomes in a retrospective study at Charles Nicolle Hospital, Tunis, Tunisia.The Pan African medical journal
  • Proliferating Cell Nuclear Antigen as New Therapeutic Target in Multiple Myeloma.Molecular cancer therapeutics
  • Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma.Haematologica
  • Practice patterns in myeloma bone disease: a multi-center survey.Frontiers in oncology
  • ALDH2 Suppresses Ferroptosis and Promotes Bortezomib Resistance in Multiple Myeloma Through the KEAP1-NRF2 Feedback Loop.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • Áttekintés[Toward a cure for multiple myeloma: multi-omics insights into disease pathogenesis and early therapeutic intervention].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Áttekintés[T-cell redirecting therapies for multiple myeloma: an update].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Áttekintés[Management of adverse events associated with quadruplet regimens, bispecific antibodies, and antibody-drug conjugates in multiple myeloma].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Áttekintés[Genomic aberrations in multiple myeloma and their therapeutic implications].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Spinal Involvement in Multiple Myeloma: A Genetically High-Risk but Biochemically Indolent Disease Phenotype.World neurosurgery
  • Ki-67 Proliferation Index Improves the Prognostic Stratification Accuracy of International Staging System in Newly Diagnosed Multiple Myeloma.Cancers
  • Infectious Complications and Toxicities of the Teclistamab Plus Daratumumab Combination in Relapsed or Refractory Multiple Myeloma: A Disproportionality and Drug-Interaction Analysis of the FDA Adverse Event Reporting System.Cancers
  • ÁttekintésMalaysian Expert Consensus Guidelines for the Diagnosis and Management of Multiple Myeloma: A Modified Delphi Approach.The Malaysian journal of medical sciences : MJMS
  • Continuous-duration maintenance therapy offers no overall survival gain in patients with newly diagnosed multiple myeloma.CA: a cancer journal for clinicians
  • Associations of Baseline Cognitive and Psychosocial Function with Clinical Outcomes After Autologous Stem Cell Transplantation in a Multiple Myeloma Sample.Cancers
  • ÁttekintésMultiple myeloma: an overview of drug therapies and supportive care.Australian prescriber
  • Multiple Myeloma in Iran: National Spatiotemporal Trends, Geographic Hotspots, and Projections to 2035.Asian Pacific journal of cancer prevention : APJCP
  • Bullous Cutaneous Amyloidosis as the Initial Manifestation of Multiple Myeloma: A Case Report.International journal of dermatology
  • Prognostic value of simultaneous [18F]FDG-PET/MRI in refractory multiple myeloma treated with anti-BCMA CAR T.HemaSphere
  • Ring-Like Nuclear Morphology in Cerebrospinal Fluid Plasma Cells in Central Nervous System Myeloma.Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Ubiquitin Protease Levels and Mitochondrial DNA Synthesis in Multiple Myeloma.Asian Pacific journal of cancer prevention : APJCP
  • ÁttekintésHead-to-Head Comparison Between [18F]FDG and [68Ga]Ga-Pentixafor PET/CT in Multiple Myeloma: A Systematic Review and Meta-Analysis.Cancers
  • Megfigyeléses vizsgálatClinical and Laboratory Factors Associated with Serious Infections in Multiple Myeloma: A Real-World Study.Current oncology (Toronto, Ont.)
  • Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta-analysis.British journal of haematology
  • Iberdomide for minimal residual disease-negative myeloma-from underdog to the spotlight.The Lancet. Oncology
  • Concurrent myelomatous pleural and pericardial effusions with cardiac tamponade in relapsed extramedullary IgA kappa multiple myeloma.BMJ case reports
  • AI-based automated body composition analysis from whole-body MRI and (PET-) CT: an intermodal comparison from same-day examinations.Cancer imaging : the official publication of the International Cancer Imaging Society
  • Megfigyeléses vizsgálatPrognostic Impact of EASIX According to the Timing of Assessment in Newly Diagnosed Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.Medical sciences (Basel, Switzerland)
  • Exploratory Identification of Potential Serum Biomarkers Associated with Relapse in Multiple Myeloma.Diseases (Basel, Switzerland)
  • Randomizált vizsgálatChallenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).Current oncology (Toronto, Ont.)
  • Patient-reported outcomes and skeletal symptoms in multiple myeloma stratified by proteasome inhibitor-based therapy: a prospective interdisciplinary cohort study.BMC cancer
  • Integrated hs-cTnI, global longitudinal strain, and coronary artery calcium for risk stratification of anthracycline-related cardiac dysfunction in multiple myeloma.Frontiers in cardiovascular medicine
  • Modeling the survival impact of the Inflation Reduction Act out-of-pocket cap in multiple myeloma.Journal of the National Cancer Institute
  • ÁttekintésAdvancing T Cell Engagers in Multiple Myeloma: Structural Design and Clinical Optimization to Address Current Limitations.Drug design, development and therapy
  • PHLPP2 expression and its clinical significance in multiple myeloma.Molecular and clinical oncology
  • Machine learning-based prognostic model and immune landscape analysis in multiple myeloma.American journal of translational research
  • Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myeloma.Frontiers in oncology
  • EsetismertetésMultiple Myeloma in a 45-Year-Old Woman with Screening-Detected Anemia and Unintentional Weight Loss: A Case Report.Reports (MDPI)
  • Association of whole-body Dixon MRI-derived abnormal bone marrow volume with prognosis in newly diagnosed multiple myeloma.Magnetic resonance imaging
  • Utilization of zoledronic acid and denosumab in patients with multiple myeloma: Real-world experience from 13 427 patients.British journal of haematology
  • Targeting lactate-driven protein lactylation overcomes proteasome inhibitor resistance in multiple myeloma.Apoptosis : an international journal on programmed cell death
  • APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma.Hematological oncology
  • Multiple myeloma in the Netherlands: 35-year trends in incidence and survival.Leukemia
  • Retrospective Application of the Current International Myeloma Working Group Disease Definitions in 20 Cats With Immunoglobulin Secreting Neoplasms.Veterinary and comparative oncology
  • The unbalanced needs and perceived supply of supportive care in family caregivers of patients with multiple myeloma: a cross-sectional study.BMC palliative care
  • EsetismertetésAortic Dissection Incidentally Detected on PET/CT During Evaluation for Suspected Multiple Myeloma.Clinical nuclear medicine
  • Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.Blood cancer journal
  • ÁttekintésEfficacy analysis and adverse event management of selinexor in the treatment of relapsed/refractory multiple myeloma.Frontiers in medicine
  • The prognostic value of KRAS, NRAS, and BRAF genes mutations in patients with newly diagnosed multiple myeloma.Leukemia research reports
  • Shikonin Promotes Apoptosis in Multiple Myeloma Cells Through the PKM2-AMPK-PGC1α Metabolic Axis.Journal of clinical laboratory analysis